- Dr. Reddy’s Laboratories (NYSE:RDY) announces the launch of Cinacalcet Tablets, a therapeutic equivalent generic version of Amgen's Sensipar (cinacalcet) Tablets.
- According to IQVIA Health, the Sensipar had U.S. sales of ~$312M for twelve months ended July 2020.
- Dr. Reddy’s Cinacalcet Tablets are available in 30, 60, and 90 mg tablets.
- https://seekingalpha.com/news/3618696-dr-reddys-launches-generic-sensipar-in-u-s
Thursday, October 1, 2020
Dr. Reddy's launches generic Sensipar in U.S.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.